2-Amino-4-methylbenzothiazole - CAS 1477-42-5
Catalog: |
BB010230 |
Product Name: |
2-Amino-4-methylbenzothiazole |
CAS: |
1477-42-5 |
Synonyms: |
4-methyl-1,3-benzothiazol-2-amine |
IUPAC Name: | 4-methyl-1,3-benzothiazol-2-amine |
Description: | 2-Amino-4-methylbenzothiazole (CAS# 1477-42-5) is a useful research chemical. |
Molecular Weight: | 164.23 |
Molecular Formula: | C8H8N2S |
Canonical SMILES: | CC1=C2C(=CC=C1)SC(=N2)N |
InChI: | InChI=1S/C8H8N2S/c1-5-3-2-4-6-7(5)10-8(9)11-6/h2-4H,1H3,(H2,9,10) |
InChI Key: | GRIATXVEXOFBGO-UHFFFAOYSA-N |
Boiling Point: | 322 °C at 760 mmHg |
Melting Point: | 279 to 282 °F |
Purity: | 98.0% |
Density: | 1.315 g/cm3 |
Appearance: | 2-amino-4-methylbenzothiazole is a white powder |
MDL: | MFCD00005793 |
LogP: | 2.76810 |
GHS Hazard Statement: | H302 (99.01%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P312, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021125803-A1 | Novel pyrimidin derivative and use thereof | 20191216 |
US-2020206225-A1 | Pyruvate kinase modulators and use thereof | 20170815 |
US-2021130371-A1 | Pyruvate kinase activators for use in treating blood disorders | 20170815 |
EP-3632903-A1 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | 20170522 |
US-2020190066-A1 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | 20170522 |
PMID | Publication Date | Title | Journal |
22226897 | 20120301 | FTIR, FT-Raman, FT-NMR, UV-visible and quantum chemical investigations of 2-amino-4-methylbenzothiazole | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
16853935 | 20051201 | Experimental and theoretical surface enhanced Raman scattering study of 2-amino-4-methylbenzothiazole adsorbed on colloidal silver particles | The journal of physical chemistry. B |
15962942 | 20050601 | Prediction of genotoxicity of chemical compounds by statistical learning methods | Chemical research in toxicology |
11425528 | 20010709 | Biological evaluation of hepatitis C virus helicase inhibitors | Bioorganic & medicinal chemistry letters |
Complexity: | 151 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 164.04081944 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 164.04081944 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 67.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzoxazole/Benzothiazole
Oxazole/Thiazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS